Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes M Van Lummel, G Duinkerken, PA Van Veelen, A De Ru, R Cordfunke, ... Diabetes 63 (1), 237-247, 2014 | 187 | 2014 |
Hydrophobic CDR3 residues promote the development of self-reactive T cells BD Stadinski, K Shekhar, I Gómez-Touriño, J Jung, K Sasaki, AK Sewell, ... Nature immunology 17 (8), 946-955, 2016 | 141 | 2016 |
T cell receptor β-chains display abnormal shortening and repertoire sharing in type 1 diabetes I Gomez-Tourino, Y Kamra, R Baptista, A Lorenc, M Peakman Nature communications 8 (1), 1792, 2017 | 80 | 2017 |
T cells in type 1 diabetes: instructors, regulators and effectors: a comprehensive review I Gomez-Tourino, S Arif, M Eichmann, M Peakman Journal of autoimmunity 66, 7-16, 2016 | 76 | 2016 |
Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule M Van Lummel, PA van Veelen, AH de Ru, J Pool, T Nikolic, S Laban, ... Diabetes 65 (3), 732-741, 2016 | 43 | 2016 |
Adaptive from innate: human IFN-γ+ CD4+ T cells can arise directly from CXCL8-producing recent thymic emigrants in babies and adults A Das, K Rouault-Pierre, S Kamdar, I Gomez-Tourino, K Wood, ... The Journal of Immunology 199 (5), 1696-1705, 2017 | 35 | 2017 |
Autoantibodies to glial fibrillary acid protein and S100β in diabetic patients I Gomez‐Tourino, F Camiña‐Darriba, I Otero‐Romero, MA Rodríguez, ... Diabetic Medicine 27 (2), 246-248, 2010 | 26 | 2010 |
GAD-alum immunotherapy in type 1 diabetes expands bifunctional Th1/Th2 autoreactive CD4 T cells S Arif, I Gomez-Tourino, Y Kamra, I Pujol-Autonell, E Hanton, T Tree, ... Diabetologia 63, 1186-1198, 2020 | 23 | 2020 |
Galectin-1 synthesis in type 1 diabetes by different immune cell types: Reduced synthesis by monocytes and Th1 cells I Gómez-Touriño, C Sánchez-Espinel, A Hernández-Fernández, ... Cellular Immunology 271 (2), 319-328, 2011 | 17 | 2011 |
Apportioning Blame: Autoreactive CD4+ and CD8+ T Cells in Type 1 Diabetes R Varela-Calvino, C Calviño-Sampedro, I Gómez-Touriño, OJ Cordero Archivum immunologiae et therapiae experimentalis 65, 275-284, 2017 | 15 | 2017 |
Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes I Gomez-Tourino, R Simon-Vazquez, J Alonso-Lorenzo, S Arif, ... Clinical & Experimental Immunology 180 (2), 207-217, 2015 | 13 | 2015 |
Exploring the Effect of Halogenation in a Series of Potent and Selective A2B Adenosine Receptor Antagonists R Prieto-Díaz, M González-Gómez, H Fojo-Carballo, J Azuaje, ... Journal of Medicinal Chemistry 66 (1), 890-912, 2022 | 9 | 2022 |
Naturally presented HLA class I–restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes C Calviño-Sampedro, I Gomez-Tourino, OJ Cordero, PA Reche, ... The FASEB Journal 33 (5), 6390, 2019 | 6 | 2019 |
Study of Plasma Anti-CD26 Autoantibody Levels in a Cohort of Treatment-Naïve Early Arthritis Patients OJ Cordero, I Viéitez, I Altabás, L Nuño-Nuño, A Villalba, ... Archivum Immunologiae et Therapiae Experimentalis 70 (1), 12, 2022 | 3 | 2022 |
Q&A: Françoise Barré-Sinoussi I Gomez-Touriño Nature 514 (7522), S8-S9, 2014 | 1 | 2014 |
Q&A: Françoise Barré-Sinoussi I Gomez-Touriño Nature 514 (7522), S8-S9, 2014 | 1 | 2014 |
Q&A: Françoise Barré-Sinoussi I Gomez-Touriño Nature 514 (7522), S8-S9, 2014 | 1 | 2014 |
PLGA-PEI nanoparticle covered with poly (I: C) for personalised cancer immunotherapy L Gonzalez-Melero, E Santos-Vizcaino, R Varela-Calvino, ... Drug Delivery and Translational Research, 1-16, 2024 | | 2024 |
POS0310 IDENTIFICATION OF NOVEL SMALL MOLECULES THROUGH UNBIASED HIGH-THROUGHPUT SCREENING FOR THE TREATMENT OF RHEUMATOID ARTHRITIS M Kotrulev, B Garcia-Pinel, R Bernardez-Alfaya, Y Lopez-Golan, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 399-399, 2023 | | 2023 |
A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma YZ Betancor, M Ferreiro-Pantin, U Anido-Herranz, M Fuentes-Losada, ... medRxiv, 2023.12. 03.23299342, 2023 | | 2023 |